BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 16763015)

  • 1. Potential impact of steatosis on cytochrome P450 enzymes of human hepatocytes isolated from fatty liver grafts.
    Donato MT; Lahoz A; Jiménez N; Pérez G; Serralta A; Mir J; Castell JV; Gómez-Lechón MJ
    Drug Metab Dispos; 2006 Sep; 34(9):1556-62. PubMed ID: 16763015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic cytochrome P450 enzyme alterations in humans with progressive stages of nonalcoholic fatty liver disease.
    Fisher CD; Lickteig AJ; Augustine LM; Ranger-Moore J; Jackson JP; Ferguson SS; Cherrington NJ
    Drug Metab Dispos; 2009 Oct; 37(10):2087-94. PubMed ID: 19651758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of steatosis on drug-metabolizing capability of primary human hepatocytes.
    Donato MT; Jiménez N; Serralta A; Mir J; Castell JV; Gómez-Lechón MJ
    Toxicol In Vitro; 2007 Mar; 21(2):271-6. PubMed ID: 16950596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effects of thiazolidinediones on in vitro P450 enzyme induction and inhibition.
    Sahi J; Black CB; Hamilton GA; Zheng X; Jolley S; Rose KA; Gilbert D; LeCluyse EL; Sinz MW
    Drug Metab Dispos; 2003 Apr; 31(4):439-46. PubMed ID: 12642470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver grafts preserved in Celsior solution as source of hepatocytes for drug metabolism studies: comparison with surgical liver biopsies.
    Donato MT; Serralta A; Jiménez N; Pérez G; Castell JV; Mir J; Gómez-Lechón MJ
    Drug Metab Dispos; 2005 Jan; 33(1):108-14. PubMed ID: 15448115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired microsomal oxidation of the atypical antipsychotic agent clozapine in hepatic steatosis.
    Zhang WV; Ramzan I; Murray M
    J Pharmacol Exp Ther; 2007 Aug; 322(2):770-7. PubMed ID: 17522342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of cytochrome P450 2C9 expression in primary cultures of human hepatocytes.
    Sahi J; Shord SS; Lindley C; Ferguson S; LeCluyse EL
    J Biochem Mol Toxicol; 2009; 23(1):43-58. PubMed ID: 19202563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of prototypical microsomal enzyme inducers on cytochrome P450 expression in cultured human hepatocytes.
    Madan A; Graham RA; Carroll KM; Mudra DR; Burton LA; Krueger LA; Downey AD; Czerwinski M; Forster J; Ribadeneira MD; Gan LS; LeCluyse EL; Zech K; Robertson P; Koch P; Antonian L; Wagner G; Yu L; Parkinson A
    Drug Metab Dispos; 2003 Apr; 31(4):421-31. PubMed ID: 12642468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of interferon-α2b on the expression of various drug-metabolizing enzymes and transporters in co-cultures of freshly prepared human primary hepatocytes.
    Chen C; Han YH; Yang Z; Rodrigues AD
    Xenobiotica; 2011 Jun; 41(6):476-85. PubMed ID: 21381897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro evaluation of hepatotoxic drugs in human hepatocytes from multiple donors: Identification of P450 activity as a potential risk factor for drug-induced liver injuries.
    Utkarsh D; Loretz C; Li AP
    Chem Biol Interact; 2016 Aug; 255():12-22. PubMed ID: 26718876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of cytochrome P450 (CYP)1A1, CYP1A2, and CYP3A4 but not of CYP2C9, CYP2C19, multidrug resistance (MDR-1) and multidrug resistance associated protein (MRP-1) by prototypical inducers in human hepatocytes.
    Runge D; Köhler C; Kostrubsky VE; Jäger D; Lehmann T; Runge DM; May U; Stolz DB; Strom SC; Fleig WE; Michalopoulos GK
    Biochem Biophys Res Commun; 2000 Jun; 273(1):333-41. PubMed ID: 10873607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryopreserved human hepatocytes as alternative in vitro model for cytochrome p450 induction studies.
    Garcia M; Rager J; Wang Q; Strab R; Hidalgo IJ; Owen A; Li J
    In Vitro Cell Dev Biol Anim; 2003; 39(7):283-7. PubMed ID: 14599235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inhibitory effect of polyunsaturated fatty acids on human CYP enzymes.
    Yao HT; Chang YW; Lan SJ; Chen CT; Hsu JT; Yeh TK
    Life Sci; 2006 Nov; 79(26):2432-40. PubMed ID: 16978661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient assessment of the utility of immortalized Fa2N-4 cells for cytochrome P450 (CYP) induction studies using multiplex quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR) and substrate cassette methodologies.
    Kenny JR; Chen L; McGinnity DF; Grime K; Shakesheff KM; Thomson B; Riley R
    Xenobiotica; 2008 Dec; 38(12):1500-17. PubMed ID: 18989830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of P450 inhibition and induction by artemisinin antimalarials in human liver microsomes and primary human hepatocytes.
    Xing J; Kirby BJ; Whittington D; Wan Y; Goodlett DR
    Drug Metab Dispos; 2012 Sep; 40(9):1757-64. PubMed ID: 22679214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of bergamottin on human and monkey drug-metabolizing enzymes in primary cultured hepatocytes.
    Wen YH; Sahi J; Urda E; Kulkarni S; Rose K; Zheng X; Sinclair JF; Cai H; Strom SC; Kostrubsky VE
    Drug Metab Dispos; 2002 Sep; 30(9):977-84. PubMed ID: 12167562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro metabolism of the calmodulin antagonist DY-9760e (3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate) by human liver microsomes: involvement of cytochromes p450 in atypical kinetics and potential drug interactions.
    Tachibana S; Fujimaki Y; Yokoyama H; Okazaki O; Sudo K
    Drug Metab Dispos; 2005 Nov; 33(11):1628-36. PubMed ID: 16049129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interindividual variation in relative CYP1A2/3A4 phenotype influences susceptibility of clozapine oxidation to cytochrome P450-specific inhibition in human hepatic microsomes.
    Zhang WV; D'Esposito F; Edwards RJ; Ramzan I; Murray M
    Drug Metab Dispos; 2008 Dec; 36(12):2547-55. PubMed ID: 18809730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The application of HepRG cells in evaluation of cytochrome P450 induction properties of drug compounds.
    Andersson TB
    Methods Mol Biol; 2010; 640():375-87. PubMed ID: 20645063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of troglitazone on cytochrome P450 enzymes in primary cultures of human and rat hepatocytes.
    Sahi J; Hamilton G; Sinz M; Barros S; Huang SM; Lesko LJ; LeCluyse EL
    Xenobiotica; 2000 Mar; 30(3):273-84. PubMed ID: 10752642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.